skip to content

Cambridge Academy of Therapeutic Sciences

 

Date: Wednesday 14 September, 4-5pm

Venue: Online

Register: Here

In the next webinar as part of the G2T seminar series, Dr Daniel Veres, Chief Scientific Officer and co-Founder of Turbine AI, Ltd will discuss ‘Simulating Cellular Biology to Facilitate Development of Precision Oncology’. Turbine is a Hungary-based company which employs machine learning to create a biologically accurate cell behaviour model, and use it as a tool for the development of new drugs, particularly aimed for cancer treatment.  Please register here.

Date: 
Wednesday, 14 September, 2022 - 16:00 to 17:00